PROSTATE CANCER SPECIFIC SURVIVAL IN SCREEN AND CLINICAL PROSTATE CANCER: A COMPARISON BETWEEN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER AND NORTHERN IRELAND

被引：0
|
作者：
Van Leeuwen, P. J. [1 ]
Connolly, D. [2 ]
Gavin, A. [3 ]
Napolitano, G. [3 ]
Kranse, R. [4 ]
Schroder, F. H. [1 ]
Roobol, M. J. [1 ]
机构：
[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[2] Belfast City Hosp, Dept Urol, Belfast BT9 7AD, Antrim, North Ireland
[3] Queens Univ Belfast, No Ireland Canc Registry, Belfast, Antrim, North Ireland
[4] Ctr Comprehens Canc, Dept Urol, Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60296-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [21] Screening for prostate cancer (PC) -: an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    Schroder, Fritz H.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) : 533 - 541
  • [22] Prostate-specific Antigen-Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer
    Bokhorst, Leonard P.
    Bangma, Chris H.
    van Leenders, Geert J. L. H.
    Lous, Jan J.
    Moss, Sue M.
    Schroder, Fritz H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2014, 65 (02) : 329 - 336
  • [23] Prostate-specific antigen change in the European Randomized Study of screening for prostate cancer, section Rotterdam
    Raaijmakers, R
    Wildhagen, MF
    Ito, K
    Pàez, A
    De Vries, SH
    Roobol, MJ
    Schröder, FH
    UROLOGY, 2004, 63 (02) : 316 - 320
  • [24] Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC)
    Lujan, M.
    Paez, A.
    Angulo, J. C.
    Granados, R.
    Nevado, M.
    Torres, G. M.
    Berenguer, A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (02) : 187 - 191
  • [25] Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC)
    M Luján
    A Páez
    J C Angulo
    R Granados
    M Nevado
    G M Torres
    A Berenguer
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 187 - 191
  • [26] CHARACTERISTIC DIFFERENCE OF PROSTATE CANCER BETWEEN KOREAN PATIENTS, EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER, ROTTERDAM GROUP AND DUTCH CLINICAL COHORT
    Park, Jae Young
    Kim, Jae Heon
    Choi, Hoon
    Shim, Ji Sung
    Bae, Jae Hyun
    Park, Hong Seok
    Moon, Du Geon
    Cheon, Jun
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A207 - A207
  • [27] Four year prostate specific antigen (PSA) progression and prostate cancer detection in the European randomized study of screening for prostate cancer (ERSPC), section Rotterdam
    Raaijmakers, R
    Schröder, FH
    De Vries, SH
    Roobol, MJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 166 - 166
  • [28] Predicting Prostate Cancer: A Comparison of the Prostate Cancer Prevention Trial Risk Calculator and the European Randomized Study of Screening for Prostate Cancer Risk Calculator in a Contemporary Irish Cohort
    Foley, R. W.
    Lundon, D. J.
    Boyce, S.
    O'Brien, F.
    Galvin, D.
    Fitzpatrick, J. M.
    Watson, R. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S18 - S19
  • [29] Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer
    Kilpelaeinen, Tuomas P.
    Talala, Kirsi
    Raitanen, Jani
    Taari, Kimmo
    Kujala, Paula
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2016, 184 (10) : 720 - 731
  • [30] Prostate cancer specific survival and metastasis-free survival in screen detected and clinically detected prostate cancer
    van Leeuwen, P. J.
    Connolly, D.
    Gavin, A.
    Roobol, M. J.
    Schroder, F. H.
    BJU INTERNATIONAL, 2009, 103 : 40 - 40
12345